Cancer care pathways mapping and dissemination toolkit: lessons learnt from cancer services in NSW, Australia by Liz M Norsa, Isaac Y Addo, Tim Shaw, Stephen Manley, Sandy Avery, Lisa J Delaney, Nicole M Rankin

“…Objective: Gaps and complexities exist in cancer referral and diagnosis in Australia, leading to delays in cancer treatments. Developing evidence-based referral pathways is important for promoting better and more timely cancer diagnosis and care. …”
Get full text

Bovine Colostrum Treatment of Specific Cancer Types: Current Evidence and Future Opportunities by Ahmad R. Alsayed, Luai Z. Hasoun, Heba A. Khader, Iman A. Basheti, Andi Dian Permana

“…Worldwide, the incidence of cancer is on the rise. Current cancer treatments include chemotherapy, radiation therapy, and surgery. …”
Get full text

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours by Jing Xue, Xia Yan, Qin Ding, Nan Li, Menghan Wu, Jianbo Song

“…Clinical trials highlight personalized immunotherapy’s positive impact on gynaecological tumor prognosis, suggesting potential avenues for future cancer treatments. However, rigorous investigation is needed to determine the exact efficacy and safety of combining NACT with immunotherapy.Conclusion: This review provides a solid foundation for the development of late-stage immunotherapy and highlights the importance of therapeutic strategies targeting immune cells in TIME in anti-tumor therapy.…”
Get full text

The Feasibility and Acceptability of a Data Capture Methodology in Pediatric Cancer Patients Treated with Targeted Agents and Immunotherapies by Karim Thomas Sadak, Taiwo Opeyemi Aremu, Seah Buttar, Daniel Van Ly, Brenda Weigel, Joseph P. Neglia

“…As childhood cancer treatments have improved to include new and innovative agents, the need for more advanced monitoring of their long-term effects and related research has increased. …”
Get full text

The Association between Spermidine/Spermine N¹-Acetyltransferase (SSAT) and Human Malignancies by Ryan Tsz-Hei Tse, Xiaofan Ding, Christine Yim-Ping Wong, Carol Ka-Lo Cheng, Peter Ka-Fung Chiu, Chi-Fai Ng

“…Drugs targeting polyamines and SSAT expression have the potential to be developed into new cancer treatments in the future.…”
Get full text

Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery by Sebastien Benizri, Ludivine Ferey, Bruno Alies, Naila Mebarek, Gaelle Vacher, Ananda Appavoo, Cathy Staedel, Karen Gaudin, Philippe Barthélémy

“…Abstract Although the application of sorafenib, a small inhibitor of tyrosine protein kinases, to cancer treatments remains a worldwide option in chemotherapy, novel strategies are needed to address the low water solubility (< 5 μM), toxicity, and side effects issues of this drug. …”
Get full text

Dual-Functionalized Nanoliposomes Achieve a Synergistic Chemo-Phototherapeutic Effect by Ana Lazaro-Carrillo, Beatriz Rodríguez-Amigo, Margarita Mora, Maria Lluïsa Sagristá, Magdalena Cañete, Santi Nonell, Angeles Villanueva

“…Bimodal chemo-phototherapeutic liposomes may have a very promising future in oncological therapy, potentially allowing a reduction in the CPT11 concentration required to achieve a therapeutic effect and overcoming resistance to individual cancer treatments.…”
Get full text

A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy by Cindy Tofthagen, Mary Tanay, Adam Perlman, Jason Starr, Pooja Advani, Katharine Sheffield, Tara Brigham

“…Chemotherapy induced peripheral neuropathy (CIPN) is a dose-limiting side effect of chemotherapy for which no prevention or cure exists. Cancer and cancer treatments can adversely affect nutritional status. …”
Get full text

Synthesis and characterization of galactomannan polymer hydrogel and sustained drug delivery by Deepika Dangi, Mansha Mattoo, Vineet Kumar, Pradeep Sharma

“…The hydrogels are used as sustained drug delivery agents for colon cancer treatments and other colonic diseases. The zero order, first order, Higuchi's and Korsmeyer-Peppas models were used to study the release kinetics of the drug, (±)-2-(p-isobutylphenyl)propionic acid. …”
Get full text

Precision Immuno-Oncology in NSCLC through Gender Equity Lenses by Jennifer Marks, Arthi Sridhar, Angela Ai, Lauren Kiel, Rebekah Kaufman, Oyepeju Abioye, Courtney Mantz, Narjust Florez

“…Precision immuno-oncology involves the development of personalized cancer treatments that are influenced by the unique nature of an individual’s DNA, immune cells, and their tumor’s molecular characterization. …”
Get full text

Unraveling the chemical identification and biological potential of the genus Asparagopsis: a comprehensive review by Kit-Leong Cheong, Kit-Leong Cheong, Guanghui Li, Guanghui Li, Min Wang, Yufeng Yang, Saiyi Zhong, Saiyi Zhong

“…Furthermore, we delve into the bioactive attributes inherent in these compounds, encompassing effects such as antioxidative, antimicrobial, and anti-inflammatory properties, as well as their conceivable role in cancer treatments. Furthermore, this review underscores the environmental pertinence of genus Asparagopsis, particularly its capacity to mitigate climate change through the generation of compounds that alleviate greenhouse gas effects. …”
Get full text

Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors by Xiujuan Yin, Xiujuan Yin, Zhenqiang He, Zhenqiang He, Weiying Ge, Zhenhua Zhao, Zhenhua Zhao, Zhenhua Zhao

“…Cancer is a major cause of human death all over the world. Traditional cancer treatments include surgery, radiotherapy, chemotherapy, immunotherapy, and hormone therapy. …”
Get full text

Management of Cardiac Toxicity Induced by Chemotherapy by Dario Trapani, Paola Zagami, Eleonora Nicolò, Gabriella Pravettoni, Giuseppe Curigliano

“…The intersection of cancer care with the management of the multiple comorbid non-communicable diseases carried by patients or related to cancer treatments motivates the need for an integrated and multidisciplinary approach to therapeutic clinical decision-making. …”
Get full text

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers by Aritro Nath, Adam L Cohen, Andrea H Bild

“…However, endocrine therapy remains the primary treatment for all advanced ER+ breast cancers. Treatment options that may benefit resistant cancers, such as add‐on drugs that target resistance pathways or switching to chemotherapy, are only available after progression on endocrine therapy. …”
Get full text

Dying to Survive—The p53 Paradox by Andrea Lees, Tamas Sessler, Simon McDade

“…However, despite an enormous amount of work identifying the breadth of the gene regulatory networks activated directly and indirectly in response to p53 activation, how p53 activation results in different cell fates in response to different stress signals in homeostasis and in response to p53 activating anti-cancer treatments remains relatively poorly understood. …”
Get full text

Potential of alisols as cancer therapeutic agents: Investigating molecular mechanisms, pharmacokinetics and metabolism by Yinqi Wu, Xijun Wang, Le Yang, Shuyu Kang, Guangli Yan, Ying Han, Heng Fang, Hui Sun

“…Based on a comprehensive analysis of nearly 20 years of research, we evaluate the therapeutic potential of alisols for various types of cancer and offer insights and strategies for developing new cancer treatments.…”
Get full text

In Silico, Combined Plasmonic Photothermal and Photodynamic Therapy in Mice by Georgios Kareliotis, Eleni Chronopoulou, Mersini Makropoulou

“…Plasmonic photothermal and photodynamic therapy (PPTT and PDT, respectively) are two cancer treatments that have the potential to be combined in a synergistic scheme. …”
Get full text

Molecular imaging biomarkers for cell-based immunotherapies by Mohammad Haris, Puneet Bagga, Hari Hariharan, Bevin McGettigan-Croce, Laura A. Johnson, Ravinder Reddy

“…These treatments are adding to the current arsenal of cancer treatments; surgery, radiation and chemotherapy, and increasing the therapeutic options for cancer patients. …”
Get full text

Local Breast Microbiota: A “New” Player on the Block by Marina Vitorino, Diogo Alpuim Costa, Rodrigo Vicente, Telma Caleça, Catarina Santos

“…As immunotherapy (such as immune checkpoint inhibitors) is becoming a promising therapy using TIME as a therapeutic target, the analysis and comprehension of local microbiota and its modulating strategies can help improve cancer treatments.…”
Get full text

Vibration Therapy for Cancer-Related Bone Diseases by Xin Song, Amel Sassi, Kimberly Seaman, Chun-Yu Lin, Lidan You

“…Patients undergoing cancer treatments and/or suffering from metastatic bone lesions experience various skeletal-related events (SREs), substantially reducing functional independence and quality of life. …”
Get full text